BioPharmaceutical Royal Rates and Deal Terms Survey
Based on the success of the initial "LES USA and Canada BioPharmaceutical Royalty Rates and Deal Terms Survey", this year LES has decided to expand the survey to a global basis. They will involve the Life Science Sector members from all 32 national and regional societies that make up our Licensing Executives Society International family. The project is being coordinated by a committee of LES USA/Canada and LESI Life Sciences Sector members.
We want to empower you to:
• Have available the latest and most accurate value-added information and key metrics
• Gain a better understanding of your industry.
• Compare your royalty rate and deal term structures to others in the licensing field based on statistically valid and representative data.
• Make strategic decisions based upon current data that is specific to your area of expertise within the licensing executive profession.
How can we do this together?
During the first week of October, please watch for an email from VERIS Consulting, inviting you to participate in this year's global study. Then at the completion of the study, look for a current and industry leading report available only to LES members.
For more information about Veris Consulting, LLC, please go to www.verisconsulting.com. If you have any questions or concerns, please call LES at +1-703-836-3106
What does the final report cost?
For LES members there is no cost to receive the final report. Your LES dues are supporting 100% of the costs of this project. But, we need your participation.
Please know that LES will not sell this report. It is available only to LES members!
"By LES Members" - "By You" → together we can provide each other with value added industry information that is not available from any other source.
It is the participation by individual members of LES, which will make a difference in the success our Global LES survey.